The global hesperidin market has emerged as a key player in the health and wellness industry, gaining substantial traction across various sectors. Valued at US$ 190.1 million in 2021, the market is anticipated to grow at a CAGR of 7.3% from 2021 to 2031, reaching a projected value of US$ 384.3 million by the end of the forecast period. This blog explores the market dynamics, key growth drivers, challenges, and opportunities shaping the hesperidin industry.
Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/hesperidin-market.html
Key Players
Key players of Hesperidin Market are Achemo Corporation, Auraleafs Labs Private Limited, BOCSCI Inc, BioCrick Co., Ltd, Benepure Corporation, Bolise Co., Limited, Chengdu Runde Pharmaceutical Co., Ltd, Morre-Tec Industries, Inc, Haihang Industry, Di’ao Pharma, NAGASE & CO., LTD, Plantnat, Zhejiang Kangle Pharmaceutical Co., Ltd, VIVAN Life Sciences, Tokyo Chemical Industry Co., Ltd
Cutaneous Functions of Hesperidin Fueling Market Growth
Hesperidin’s cutaneous benefits have garnered significant attention, particularly during the COVID-19 pandemic, as consumers sought health-boosting solutions. Its anti-inflammatory, antioxidant, and antibacterial properties make it a preferred ingredient in wound healing, UV protection, and anti-aging treatments.
Key Cutaneous Functions:
- Wound Healing: Speeds up skin recovery by promoting cellular repair.
- UV Protection: Shields skin from harmful ultraviolet rays.
- Anti-inflammatory Effects: Reduces redness and irritation.
- Antimicrobial Benefits: Helps in fighting bacterial infections.
Hesperidin’s affordability, availability, and safety are critical factors driving its adoption in the cosmetics and personal care industries.
Regional Insights: North America at the Forefront
Key Drivers in North America:
North America is expected to dominate the global hesperidin market during the forecast period, driven by:
- High prevalence of chronic diseases such as cardiovascular conditions and diabetes.
- Robust growth in the healthcare and pharmaceutical industries.
- Increased investments in R&D activities by key market players.
The U.S. is projected to consume 1,776 MT of hesperidin by the end of 2021, accounting for 88.35% of the North American market share. The region’s volume CAGR of 5.7% underscores its potential for sustained growth.
Challenges: Suboptimal Utilization of Raw Materials
Despite its growth prospects, the hesperidin market faces challenges related to the inefficient utilization of raw materials. For instance:
- Citrus processing residues (CPR) account for 40%-50% of citrus fruit production.
- However, only 5% of CPR is utilized to produce bioflavonoids like hesperidin.
Efforts to enhance the extraction and utilization of CPR can unlock significant market opportunities while addressing environmental concerns related to waste management.
Contact:
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
